Your account is not claimed yet. You can sign up with ORCID to claim your account.

Silvia T Cardona (Silvia Cardona)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 14

Top Venues

Antibiotics (Basel, Switzerland)

Antimicrobial agents and chemotherapy

Pathogens and disease

FEMS microbiology reviews

University of Manitoba

University of Chile (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Manitoba Apr 1o 2006

Canada

Professor :: Microbiology

Education History

University of Chile

Chile

PHD

Publications

Beltina León, Daniela Casco, Marisa Bettiol, Mariana Leguizamón, Virginia D Alessandro, Claudia Prieto, Carolina Vita, Cecilia Beatriz Figoli, Cecilia Vescina, Fernando Rentería, Silvia T Cardona, Alejandra Bosch
The Burkholderia contaminans prevalent phenotypes as possible markers of poor clinical outcomes in chronic lung infection of children with cystic fibrosis. Pathogens and disease (2023)
Andrew M Hogan, A S M Zisanur Rahman, Anna Motnenko, Aakash Natarajan, Dustin T Maydaniuk, Beltina León, Zayra Batun, Armando Palacios, Alejandra Bosch, Silvia T Cardona
Profiling cell envelope-antibiotic interactions reveals vulnerabilities to β-lactams in a multidrug-resistant bacterium. Nature communications 14 (1) (2023)
Zhong Ling Yap, Anna Motnenko, Silvia T Cardona
Complete Genome Sequence of Burkholderia vietnamiensis LMG16232. Microbiology resource announcements (2023)
Anna J Hooppaw, Jenna C McGuffey, Gisela Di Venanzio, Juan C Ortiz-Marquez, Brent S Weber, Tasia Joy Lightly, Tim van Opijnen, Nichollas E Scott, Silvia T Cardona, Mario F Feldman
The Phenylacetic Acid Catabolic Pathway Regulates Antibiotic and Oxidative Stress Responses in Acinetobacter. mBio 13 (3) (2022)
A S M Zisanur Rahman, Chengyou Liu, Hunter Sturm, Andrew M Hogan, Rebecca Davis, Pingzhao Hu, Silvia T Cardona
A machine learning model trained on a high-throughput antibacterial screen increases the hit rate of drug discovery. PLoS computational biology 18 (10) (2022)
Andrew M Hogan, Silvia T Cardona
Gradients in gene essentiality reshape antibacterial research. FEMS microbiology reviews 46 (3) (2022)
Dustin Maydaniuk, Bin Wu, Dang Truong, Sajani H Liyanage, Andrew M Hogan, Zhong Ling Yap, Mingdi Yan, Silvia T Cardona
New Auranofin Analogs with Antibacterial Properties against Burkholderia Clinical Isolates. Antibiotics (Basel, Switzerland) 10 (12) (2021)
Tasia Joy Lightly, Kara L Frejuk, Marie-Christine Groleau, Laurent Roberto Chiarelli, Cor Ras, Silvia Buroni, Éric Déziel, John L Sorensen, Silvia T Cardona
Phenylacetyl Coenzyme A, Not Phenylacetic Acid, Attenuates CepIR-Regulated Virulence in Burkholderia cenocepacia. Applied and environmental microbiology 85 (24) (2019)
Andrew M Hogan, A S M Zisanur Rahman, Tasia J Lightly, Silvia T Cardona
A Broad-Host-Range CRISPRi Toolkit for Silencing Gene Expression in Burkholderia. ACS synthetic biology 8 (10) (2019)
Jaroslav Nunvar, Andrew M Hogan, Silvia Buroni, Svetlana Savina, Vadim Makarov, Silvia T Cardona, Pavel Drevinek
The Effect of 2-Thiocyanatopyridine Derivative 11026103 on Burkholderia Cenocepacia: Resistance Mechanisms and Systemic Impact. Antibiotics (Basel, Switzerland) 8 (4) (2019)
Andrew M Hogan, Viola C Scoffone, Vadim Makarov, April S Gislason, Haben Tesfu, Maria S Stietz, Ann Karen C Brassinga, Michael Domaratzki, Xuan Li, Alberto Azzalin, Marco Biggiogera, Olga Riabova, Natalia Monakhova, Laurent Roberto Chiarelli, Giovanna Riccardi, Silvia Buroni, Silvia T Cardona
Competitive Fitness of Essential Gene Knockdowns Reveals a Broad-Spectrum Antibacterial Inhibitor of the Cell Division Protein FtsZ. Antimicrobial agents and chemotherapy 62 (12) (2018)
Silvia T Cardona, Matthew Choy, Andrew M Hogan
Essential Two-Component Systems Regulating Cell Envelope Functions: Opportunities for Novel Antibiotic Therapies. The Journal of membrane biology 251 (1) (2017)
Maria Sol Haim, Marta Mollerach, Gary Van Domselaar, Sergio A Teves, José Degrossi, Silvia T Cardona
Draft Genome Sequences of Burkholderia contaminans FFI-28, a Strain Isolated from a Contaminated Pharmaceutical Solution. Genome announcements 4 (5) (2016)
April S Gislason, Matthew Choy, Ruhi A M Bloodworth, Wubin Qu, Maria S Stietz, Xuan Li, Chenggang Zhang, Silvia T Cardona
Competitive Growth Enhances Conditional Growth Mutant Sensitivity to Antibiotics and Exposes a Two-Component System as an Emerging Antibacterial Target in Burkholderia cenocepacia. Antimicrobial agents and chemotherapy 61 (1) (2016)

Silvia T Cardona.css-eqlu8i{font-size:small;padding-left:4px;} (Silvia Cardona)

Publication Activity (10 Years)

Top Topics

Top Venues

Silvia T Cardona (Silvia Cardona)